Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FE0FX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,500
Award facts
- Contract value 100% obligated
- $32,499.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on September 8, 2025. The delivery order, issued under the SPE2DB Indefinite Delivery Contract (valued at $499,999,999 through November 2026), calls for the delivery of Stelara 90 mg/mL syringes to support Department of Defense healthcare facilities. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal pharmaceutical supply market. Performance is scheduled for completion by September 29, 2025, with fulfillment at the company's Park Ridge, Illinois location.
This delivery order represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain. The company has demonstrated consistent success in securing DLA contracts for a diverse portfolio of pharmaceutical products, including biologics, prescription medications, and medical consumables serving military health facilities nationwide. Stelara, a biologic immunosuppressant medication, reflects the company's capability to distribute specialized pharmaceutical products essential to the Department of Defense's medical supply operations.
Quick answers
Who was awarded contract SPE2DB25FE0FX?
SPE2DB25FE0FX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FE0FX worth?
The government has obligated $32,500 on SPE2DB25FE0FX.
Is contract SPE2DB25FE0FX an order under another contract?
Yes. SPE2DB25FE0FX is a delivery order under SPE2DB22D9130, an indefinite delivery contract.
Was contract SPE2DB25FE0FX competed?
The extent of competition for SPE2DB25FE0FX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award